InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（2 笔）
内部人交易记录
其他已披露买入
1
已披露卖出
2
T+90 胜率
0%
T+90 平均收益
-20.0%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the complete record of transactions filed by Kamdar Kim P.. Officer active across 4 companies, notably Singular Genomics Systems, Inc.. Cumulatively, 10 disclosures have been published. Breakdown: 1 buy · 2 sells. Total volume traded: €202k. History available since 18 June 2021. The latest transaction was filed on 10 July 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Kamdar Kim P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
22,426 股0Class A Common StockSEC:0001535065-26-000002:0
3,421 股0Class A Common StockSEC:0001535065-26-000002:1
30,920 股0Class A Common StockSEC:0001193125-26-037807:0
15,596 股0Class A Common StockSEC:0000950170-25-083335:0
15,000 股Common StockSEC:0000950170-25-027096:0
7,117 股0Class A Common StockSEC:0001534969-24-000133:0
10 股@ US$0.621100.0% 占其流量Common StockSEC:0001493152-23-045912:0
353,657 股@ US$0.5955100.0% 占其流量Common StockSEC:0001209191-23-045925:0
10,000 股@ US$1.165100.0% 占其流量Common StockSEC:0001618835-21-000156:0
标准退出：2021年9月16日 (T+90)
4,395,633 股Common StockSEC:0000904454-21-000498:0
10 条申报中的 10 条
About Kamdar Kim P.
Kamdar Kim P. is a Director at Sera Prognostics, INC., Singular Genomics Systems, Inc. and Evofem Biosciences, Inc. The declarant has 10 filings in total; across the 10 sampled filings, buys total 9779 EUR and sells total 191783 EUR, with a date range from 2021-06-01 to 2026-07-14. The modal transaction nature is Attribution.
